UBE2V1P4

Across TCGA pan-cancer cohorts, UBE2V1P4 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated UBE2V1P4 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher UBE2V1P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBE2V1P4 expression acts as an unfavorable survival marker.

READ, CESC, and UCS are the cancer types where UBE2V1P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.133	0.731	<.001	108	view →
CESC	OS	Tertile	All	0.752	0.879	.040	24	view →
UCS	DFS	Tertile	All	0.184	0.528	.043	18	view →
TGCT	DFS	Tertile	All	0.091	0.683	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

UBE2V1P4–READ (DFS)

Open the READ breakdown →